Comparison of serum sIL-2R and LDH levels in patients with intravascular large B-cell lymphoma and patients with advanced stage diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Comparison of serum sIL-2R and LDH levels in patients with intravascular large B-cell lymphoma and patients with advanced stage diffuse large B-cell lymphoma

Published:2022 Issue:1 Volume:63 Page:25-31
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:J Clin Exp Hematopathol

Author:

Hirami Yuki¹,Nishimura Midori Filiz²,Urata Tomohiro³,Morimoto Michiko¹,Maekawa Yukina²,Yoshino Tadashi⁴,Nishimura Yoshito⁵,Sato Yasuharu²

Affiliation:

1. Department of Nursing, Okayama University Graduate School of Health Sciences, Okayama, Japan,

2. Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,

3. Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan,

4. Department of Pathology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan,

5. Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan,

Publisher

Japanese Society for Lymphoreticular Tissue Research

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jslrt/63/1/63_22043/_pdf

Reference20 articles.

1. 1 Swerdlow SH. International Agency for Research on C: WHO Classification of Tumours. 4th ed, Lyon, International Agency for Research on Cancer. 2017.

2. 2 Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid neoplasms. Leukemia. 2022; 36: 1720-1748.

3. 3 Shimada K, Yamaguchi M, Atsuta Y et al. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2020; 21: 593-602.

4. 4 Shimada K, Kinoshita T, Naoe T, Nakamura S. Presentation and management of intravascular large B-cell lymphoma. Lancet Oncol. 2009; 10: 895-902.

5. 5 Davis JW, Auerbach A, Crothers BA et al. Intravascular large B-cell lymphoma. Arch Pathol Lab Med. 2022; 146: 1160-1167.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature;Brain Tumor Pathology;2024-04

2. Asian Variant Intravascular Lymphoma: A Look at the Laboratory Data of Lactase Dehydrogenase and Soluble Interleukin-2 Receptor;Cureus;2023-12-09

3. Lymphoma-related intussusception in children: diagnostic challenges and clinical characteristics;European Journal of Pediatrics;2023-10-20